By Josh Beckerman
Avinger shares fell after the company said it would seek shareholder approval for a potential assignment for the benefit of creditors followed by a voluntary dissolution and liquidation.
The medical-device company's stock was down 27%, to 60 cents, in after hours Wednesday after closing flat, at 82 cents.
Avinger said in a proxy filing that it expects to continue to generate operating losses and consume significant cash resources for the foreseeable future. It doesn't expect its cash and cash equivalents to be sufficient to continue as a going concern for any significant period of time.
"Although we are currently exploring various strategic alternatives, including strategic partners and financing opportunities, it is unlikely that these strategic alternatives will be successful in the next few weeks prior to our cash position getting to the point that we will need to pursue our winding down and dissolution," the company said.
Write to Josh Beckerman at josh.beckerman@wsj.com
(END) Dow Jones Newswires
December 11, 2024 18:58 ET (23:58 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。